Neogenomics, Inc. (NEO) fundamentals score
NeoGenomics provides a wide range of oncology diagnostic testing and consultative services including technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts who specialize in pathology and oncology.
Services-Testing Laboratories · Industrials · Listed on NASDAQ
Overall: 5.4 out of 10, Mixed fundamentals
- Growth: 5.2/10
- Profitability: 4.0/10
- Financial health: 4.8/10
- Earnings quality: 9.0/10
- Valuation: 5.2/10
Scores are calculated from Neogenomics, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Industrials stocks
- Sezzle Inc. (SEZL): 9.1/10
- Paymentus Holdings, Inc. (PAY): 8.7/10
- Argan Inc. (AGX): 8.6/10
- Ferguson Enterprises Inc. (FERG): 8.6/10
- International Seaways, Inc. (INSW): 8.6/10
- Dorian Lpg Ltd. (LPG): 8.6/10
- Quinstreet, Inc. (QNST): 8.6/10
- Remitly Global, Inc. (RELY): 8.6/10